A clinical case of HIV-associated non-Hodgkin's lymphoma of the kidney with pulmonary dissemination syndrome. Case report
- Authors: Tselishcheva L.I.1, Afanasiev E.I.2, Larionova E.A.3, Perevoshchikova A.D.4, Opolonskiy D.V.2
-
Affiliations:
- Regional Clinical Medical Center for Phthisiopulmonology and Infectious Diseases
- Izhevsk State Medical Academy
- Kazan State Medical University
- Bureau of Forensic Medicine
- Issue: Vol 27, No 12 (2025): Comorbidity in internal medicine
- Pages: 794-799
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/380231
- DOI: https://doi.org/10.26442/20751753.2025.12.203417
- ID: 380231
Cite item
Full Text
Abstract
The incidence of HIV infection continues to rise over the past several decades, causing serious concern among healthcare professionals. Human Immunodeficiency Virus (HIV) destroys the immune system, significantly reducing its protective functions and increasing the body's vulnerability to the development of oncological diseases. According to various authors, HIV-associated neoplasms tend to be more aggressive, and in most cases, the diagnosis is made at advanced stages, when the neoplasm has often spread to organs and systems distant from the primary site. A significant factor in this is the prolonged diagnosis of oncological diseases in HIV-infected patients, which is related to the complexity of interpreting research data and the similarity of the clinical picture of oncological processes with a range of other diseases and conditions associated with HIV. The reduction in CD4+ cell counts, the ineffectiveness of CD8+ cell responses, and the resulting immune dysregulation lead to a weakening of local immune surveillance. The functional activity of CD4+ cells is also crucial, as it influences tumor antigen recognition, the production of effective anti-tumor antibodies, and the response to oncogenic viral invasion – another pathogenetic factor contributing to the development of oncological diseases in the context of HIV. Likely, this contributes to early tumor dissemination even at initial disease stages, with pronounced involvement of extralymphatic organs and systems, due to the absence of barriers to hematogenous metastasis. Such early dissemination serves as additional evidence of significant impairments in anti-tumor immune control in HIV-infected individuals at all stages of malignant neoplasm development. Therefore, it is critically important for at-risk groups to maintain vigilance, undergo regular medical examinations, and promptly identify potential complications. This study presents a clinical case of a 30-year-old patient who developed non-Hodgkin's lymphoma and disseminated lung syndrome against the background of HIV infection. These data help to better understand the challenges of diagnosing and treating this combination of diseases and provide valuable information for improving medical care for patients with HIV.
About the authors
Liudmila I. Tselishcheva
Regional Clinical Medical Center for Phthisiopulmonology and Infectious Diseases
Email: ya.afanasev-efim@yandex.ru
ORCID iD: 0009-0006-9426-5369
phthisiologist
Russian Federation, EkaterinburgEfim I. Afanasiev
Izhevsk State Medical Academy
Author for correspondence.
Email: ya.afanasev-efim@yandex.ru
ORCID iD: 0000-0002-7310-3014
Cand. Sci. (Med.)
Russian Federation, IzhevskEkaterina A. Larionova
Kazan State Medical University
Email: ya.afanasev-efim@yandex.ru
ORCID iD: 0009-0001-6028-2244
Medical Resident
Russian Federation, KazanAlina D. Perevoshchikova
Bureau of Forensic Medicine
Email: ya.afanasev-efim@yandex.ru
forensic expert
Russian Federation, IzhevskDmitriy V. Opolonskiy
Izhevsk State Medical Academy
Email: ya.afanasev-efim@yandex.ru
ORCID iD: 0000-0001-9559-2106
Cand. Sci. (Med.)
Russian Federation, IzhevskReferences
- Афанасьев Е.И. Совершенствование профилактических противотуберкулезных мероприятий среди больных ВИЧ-инфекцией в Удмуртской Республике. Дисс. ... канд. мед. наук. ФГБНУ ЦНИИТ. 2022 [Afanasev EI. Sovershenstvovanie profilakticheskikh protivotuberkuleznykh meropriiatii sredi bolnykh VICh-infektsiei v Udmurtskoi Respublike. Diss. ... kand. med. nauk. FGBNU TsNIIT. 2022 (in Russian)].
- Русакова Л.И., Кучерявая Д.А., Эргешов А.Э. Эпидемиология туберкулеза, сочетанного с ВИЧ, в современных условиях. Современные проблемы здравоохранения и медицинской статистики. 2024;(5):19-32 [Rusakova LI, Kucheryavaya DA, Ergeshov AE. Epidemiology of tuberculosis combined with hiv in modern conditions. Current problems of health care and medical statistics. 2024;(5):19-32 (in Russian)]. doi: 10.24412/2312-2935-2024-5-19-32
- Martinez L, Andrews JR. Improving Tuberculosis Case Finding in Persons Living with Advanced HIV through New Diagnostic Algorithms. Am J Respir Crit Care Med. 2019;199(5):559-60. doi: 10.1164/rccm.201809-1702ED
- Hevroni G, Mostel Z, Skwiersky S, et al. HIV-associated Hodgkin Lymphoma with a granulomatous bone marrow biopsy: A case report. Am J Med Case Rep. 2021;9(1):83-7. doi: 10.12691/ajmcr-9-1-21
- Афанасьев Е.И., Русских О.Е. Многолетний сравнительный анализ основных эпидемиологических показателей по туберкулезу в сочетании с ВИЧ-инфекцией в Удмуртской Республике. Туберкулез и болезни легких. 2020;98(9):18-23 [Afanasiev EI, Russkikh OE. Long-term comparative analysis of the main epidemiological indicators for tuberculosis in combination with hiv infection in the Udmurt Republic. Tuberkulez i bolezni Legkikh. 2020;98(9):18-23 (in Russian)]. doi: 10.21292/2075-1230-2020-98-9-18-23
- Афанасьев Е.И., Русских О.Е. Эпидемическая ситуация по туберкулезу внелегочных локализаций в Удмуртской Республике. Туберкулез и болезни легких. 2019;97(11):60-1 [Afanasiev EI, Russkikh OE. Extrapulmonary tuberculosis epidemic situation in the Udmurt Republic. Tuberkulez i bolezni legkikh. 2019;97(11):60-1 (in Russian)]. doi: 10.21292/2075-1230-2019-97-11-60-61
- Максимов Н.И., Сысоев П.Г., Афанасьев Е.И., и др. Структура сопутствующей патологии у больных внелегочным туберкулезом в УР. Естественные и технические науки. 2019;5(131):108-10 [Maksimov NI, Sysoev PG, Afanasyev EI. The structure of comorbidities in patients with extrapulmonary tuberculosis in UR. Estestvennye i tekhnicheskie nauki. 2019;5(131):108-10 (in Russian)]. EDN:XDBJKV
- Гаджикулиева М.М., Цветкова О.О., Чернышева О.О., Тишкевич О.А. Клинический случай ВИЧ-ассоциированной лимфомы. Инфекционные болезни: новости, мнения, обучение. 2023;12(2):120-6 [Gadzhikulieva MM, Tsvetkova OО, Chernysheva OО, Tishkevich OА. HIV-assosiated lymphoma: A case report. Infektsionnye Bolezni: Novosti, Mneniia, Obuchenie. 2023;12(2):120-6 (in Russian)]. doi: 10.33029/2305-3496-2023-12-2-120-126
- Lamers SL, Fogel GB, Huysentruyt LC, McGrath MS. HIV-1 nef protein visits B-cells via macrophage nanotubes: a mechanism for AIDS-related lymphoma pathogenesis. Curr HIV Res. 2010;8(8):638-40. doi: 10.2174/157016210794088209
- Berhan A, Bayleyegn B, Getaneh Z. HIV/AIDS associated lymphoma: Review. Blood Lymphat Cancer. 2022;12(3):1-45. doi: 10.2147/BLCTT.S361320
- de Carvalho PS, Leal FE, Soares MA. Clinical and molecular properties of human immunodefi ciency virus-related diffuse large B-cell lymphoma. Front Oncol. 2021;11:675353. doi: 10.3389/fonc.2021.675353
- Pongas GN, Ramos JC. HIV-associated lymphomas: Progress and new challenges. J Clin Med. 2022;11(5):1447. doi: 10.3390/jcm11051447
- Пивник А.В., Туманова М.В., Серегин Н.В., и др. Лимфомы у ВИЧ-инфицированных больных: обзор литературы. Клиническая онкогематология. 2014;7(3):264-77 [Pivnik AV, Tumanova MV, Seregin NV. Lymphomas in HIV-infected patients: literature review. Klinicheskaia Onkogematologiia. 2014;7(3):264-77 (in Russian)]. EDN:SZGXUR
- Riedel DJ. HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population. Leuk Lymphoma. 2016;57(2):306-12. doi: 10.3109/10428194.2015.1055483
- Wang C, Liu J, Liu Y. Progress in the treatment of HIV-associated lymphoma when combined with the antiretroviral therapies. Front Oncol. 2022;11:798008. doi: 10.3389/fonc.2021.798008
- Hoffmann C, Wolf E, Fatkenheuer G, et al. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS. 2003;17:1521-9. doi: 10.1097/00002030-200307040-00013
- Lim ST, Karim R, Nathwani BN, et al. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol. 2005;23(19):4430-8. doi: 10.1200/JCO.2005.11.973
- Dudina GA, Mabudzadа ChK, Ogannisyan AA, Nemikin VN. HIV-associated lymphomas. Creative Surgery and Oncology. 2022;12(4):320-7. doi: 10.24060/2076-3093-2022-12-4-320-327
- Chen J, Liu X, Qin S, et al. A novel prognostic score including the CD4/CD8 for AIDSrelated lymphoma. Front Cell Infect Microbiol. 2022;12:919446. doi: 10.3389/fcimb.2022.919446
- Baptista MJ, Garcia O, Morgades M, et al. HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era. AIDS. 2015;29(7):811-8. doi: 10.1097/QAD.0000000000000624
Supplementary files

